Peter Bou Dib: How Factor IX Transformed Hemophilia B Treatment
Peter Bou Dib, Key Account Manager at Sino Biological Europe, shared a post on LinkedIn:
“Every day, thousands rely on a tiny but mighty protein to keep their blood flowing safely, Factor IX.
This protein, discovered from a young patient named Stephen Christmas, quietly plays a life-saving role in the complex dance of blood clotting.
Without Factor IX, people with Hemophilia B face constant risks of severe bleeding, impacting their daily lives and dreams.
Thanks to decades of research and innovation, treatments like recombinant Factor IX and emerging gene therapies offer hope and freedom.
Science continues to transform challenges into possibilities, turning a rare protein deficiency into a story of resilience and renewed life.
Here’s to the breakthroughs that rewrite what’s possible.
Want to learn more about proteome in under a minute every day?
Follow Five days, one play, one antigen each day!”

Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering